Company / Working Capital per Share
Apellis Pharmaceuticals, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.55
FY2025
5-year range
$4.68 / $9.09
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#104 of 210
Health Care
What the data says
At $5.55, Apellis Pharmaceuticals, Inc.'s working capital per share ranks #104 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $2.82 in FY2016 to $12.65 in FY2017.
Based on SEC 10-K filings.
5.55 in FY2025 with a 5-year CAGR of -14.8%.
Improved from $4.68 to $5.55 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -0.6%
- 5-Year CAGR
- -14.8%
- 10-Year CAGR
- -
Sector benchmark
#104 of 210 in Health CareTop 50% of 210This company $5.55 Sector average $146.86
▼
-96.2% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 10.0% year-over-year.
- Ranks #104 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2017.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.55 | +10.0% |
| FY2024 | $5.05 | +7.8% |
| FY2023 | $4.68 | -17.3% |
| FY2022 | $5.66 | -37.8% |
| FY2021 | $9.09 | -26.3% |
| FY2020 | $12.34 | +149.8% |
| FY2019 | $4.94 | +44.9% |
| FY2018 | $3.41 | -73.1% |
| FY2017 | $12.65 | +349.3% |
| FY2016 | $2.82 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026